MesotheliomaLaw.News

Tag: mesothelioma

  • 2025 Alton Miles for Meso Raises Over $25,000 and Unites Hundreds of Racers for Asbestos Prevention and a Cure

    Calling all runners, walkers, and mesothelioma warriors! It’s time to lace up your shoes for a cause. The 17th Annual Miles for Meso Race is happening on September 20, 2025. This popular event, organized by Simmons Hanly Conroy, aims to raise awareness of asbestos-related diseases and inspire hope for finding a cure.

    This year, we’re proud to introduce Penny Jo Major, the team captain of ADAO’s (Asbestos Disease Awareness Organization) Ban Asbestos Miles for Meso Team. Penny Jo is a fierce advocate for asbestos prevention and is eager to lead the team this year.

    The event includes a competitive 5K race and a 3K fun run/walk, offering options for both fitness enthusiasts and those who prefer a leisurely pace. The Alton Miles for Meso 5K Race and 3K Fun Run/Walk promise a day filled with camaraderie, fitness, and dedication to an important cause.

    In 2025, the Alton Miles for Meso event raised over $25,000 and brought together hundreds of participants. It’s not just a race; it’s a statement of solidarity against asbestos and its harmful effects. And with the ADAO launching new initiatives, we’re hopeful for an even bigger turnout this year.

    Join us in the fight against mesothelioma. Register today for the Miles for Meso race and take a step towards a world free of asbestos-related diseases.

    For more details on the race and how to register, visit the ADAO website. Let’s make strides together in the fight against mesothelioma!

    Original source: ADAO – Asbestos Disease Awareness Organization

  • Mesothelioma Awareness Month: Thirty Irrefutable Asbestos and Mesothelioma Facts for Thirty Days

    As September rolls around, the Asbestos Disease Awareness Organization (ADAO) gears up for Mesothelioma Awareness Month. This is a time of reflection, remembrance, and most importantly, action. The goal is not just to raise awareness about the deadly disease but also to take decisive steps towards its elimination. The ADAO is committed to eliminating not just mesothelioma, but all diseases caused by asbestos exposure.

    Throughout the month, ADAO will be sharing a plethora of facts, resources, and opportunities for you, the reader, to get involved. The organization aims to shed light on asbestos-related diseases, including mesothelioma, and the devastating effects they have on people’s lives.

    In line with this, ADAO has published “Mesothelioma Awareness Month: Thirty Irrefutable Asbestos and Mesothelioma Facts for Thirty Days” on their blog. This comprehensive resource is aimed to educate, inform, and ignite action against asbestos exposure.

    Stay tuned to the ADAO newsroom for more on this, and other mesothelioma-related news. With your help, we can work towards a world free of asbestos-related diseases.

    Original source: ADAO – Asbestos Disease Awareness Organization

  • Mesothelioma Awareness Month: Honoring Lives, Demanding Action

    Mark your calendars this September for Mesothelioma Awareness Month. A time where we come together to honor the memory of those who’ve tragically lost their battles with this aggressive form of cancer, offer our support to those currently facing the fight, and push for proactive measures to prevent asbestos exposure.

    The significance of Mesothelioma Awareness cannot be overstated. Mesothelioma is a rare yet aggressive kind of cancer, primarily caused by exposure to asbestos. This makes raising awareness and advocating for the prevention of asbestos exposure a matter of life and death.

    For more information and to engage further in this critical cause, check out the original post “Mesothelioma Awareness Month: Honoring Lives, Demanding Action” on the Asbestos Disease Awareness Organization’s (ADAO) website. The ADAO continues to be a leading voice in the fight against asbestos-related diseases, providing an invaluable resource for those interested in mesothelioma legal news.

    Original source: ADAO – Asbestos Disease Awareness Organization

  • Remembering Karen Grant – A Beacon of Hope and Joy

    In Memoriam: Karen Grant – A Shining Light in the Fight for Justice

    On September 4, 2025, the mesothelioma community lost a resolute defender of justice and shining example of resilience – Karen Grant. At the age of 29, Karen received a diagnosis that would change her life. Yet, she courageously turned her battle with mesothelioma into a heartening journey of love, hope, and joy.

    Karen’s impact on the mesothelioma community extended beyond her personal fight. Her powerful voice and unyielding spirit became a beacon of hope for others facing the same formidable disease. Her story served as a living testament to the tenacity of the human spirit in the face of adversity and a reminder of the pressing need for justice and awareness.

    To learn more about Karen’s inspiring journey and her significant contributions to the fight against mesothelioma, visit the Asbestos Disease Awareness Organization’s blog post: [Remembering Karen Grant – A Beacon of Hope and Joy](https://www.asbestosdiseaseawareness.org/newsroom/blogs/remembering-karen-grant/).

    Stay tuned to [ADAO – Asbestos Disease Awareness Organization](https://www.asbestosdiseaseawareness.org) for more updates and news about mesothelioma and the ongoing fight for justice.

    Original source: ADAO – Asbestos Disease Awareness Organization

  • Blood test spots hidden mesothelioma that scans can’t see

    The realm of mesothelioma legal news has been buzzing recently with new revelations regarding potential treatment options for patients suffering from diffuse pleural mesothelioma, an arduous form of cancer notoriously difficult to treat. Fresh research has emerged, pointing to an exciting possibility – immunotherapy given both pre and post-surgery could significantly aid the battle against this disease.

    The promising findings have come to light following a phase II clinical trial which tested the efficacy of immunotherapy in cases where tumors could be surgically removed. The results of the trial have been highly encouraging, sparking hope among the medical community, patients, and their families alike.

    Diffuse pleural mesothelioma, a cancer that affects the lining of the lungs, is a daunting diagnosis. The disease is commonly associated with exposure to asbestos, a fact which has led to numerous legal battles around the world. As a result, advances in treatment are not only medically significant but also hold substantial implications for ongoing and future legal cases.

    Immunotherapy, a treatment that utilizes the body’s own immune system to fight cancer, represents one of the latest frontiers in cancer treatment. The use of this treatment before and after surgery could potentially increase survival rates and improve the quality of life for patients battling diffuse pleural mesothelioma.

    The favorable findings from the phase II clinical trial have undeniably ignited a sense of cautious optimism. While it’s important to remember that these findings are preliminary, they certainly pave the way for more in-depth research and trials. As always, the goal remains to find the most effective methods to combat, and ultimately cure, this challenging disease.

    As the medical world continues to delve into the potential of immunotherapy for mesothelioma patients, those interested in legal news surrounding the disease will no doubt be watching closely. As breakthroughs in treatment can significantly impact legal proceedings, this emerging research could potentially reshape the landscape of mesothelioma litigation.

    Stay tuned for more mesothelioma legal news as we continue to follow this groundbreaking research and its potential implications for patients and legal professionals alike.

    Original source: Science Daily

  • Oncovita receives FDA Orphan Drug Designation for its lead oncolytic virus candidate MVdeltaC in the treatment of pleural mesothelioma

    In an exciting development for the medical and legal communities, Oncovita has been granted Orphan Drug Designation by the Food and Drug Administration (FDA) for its pioneering oncolytic virus treatment, MVdeltaC. This ground-breaking treatment is specifically designed to target pleural mesothelioma, a rare and often aggressive form of cancer typically linked to asbestos exposure.

    The news originated from Paris, where Oncovita, a biotech startup specializing in cancer immunotherapy, is based. The company’s breakthrough in gaining FDA approval is a significant step forward in the fight against this deadly disease.

    Orphan Drug Designation is a unique status given by the FDA to drugs and biologics that are intended for the safe and effective treatment, diagnosis, or prevention of rare diseases/disorders that affect fewer than 200,000 people in the U.S. This special designation provides incentives such as tax credits for clinical testing, exemption from FDA application fees, and potential seven-year market exclusivity upon approval.

    The designation of MVdeltaC as an orphan drug underscores the potential of Oncovita’s innovative treatment strategy. MVdeltaC is an oncolytic virus, a type of treatment that uses viruses to kill cancer cells. In particular, MVdeltaC has shown noteworthy potential in treating pleural mesothelioma, a cancer that forms in the lining of the lungs and is most often caused by inhalation of asbestos fibers.

    This is a substantial development for victims of asbestos exposure and their families, who may see this as a beacon of hope in their fight against mesothelioma. The progression of new treatments like MVdeltaC brings optimism and the potential for longer survival times for patients suffering from this devastating disease.

    This story also has significant implications for the legal landscape surrounding mesothelioma and asbestos. The development of new treatments and the FDA’s recognition of these advances could influence future litigation and settlements related to asbestos exposure.

    In conclusion, Oncovita’s achievement of FDA Orphan Drug Designation for MVdeltaC represents a promising development in the field of mesothelioma treatment. This progress could bring new hope to patients and families affected by this rare but deadly form of cancer, while potentially affecting the legal environment surrounding asbestos-related lawsuits.

    Original source: GlobeNewswire

  • 10th ADAO Asbestos Awareness and Prevention Conference in Washington, DC Video (2014)

    Are you interested in the latest developments in mesothelioma and asbestos-related diseases? If so, we have some exciting news for you. The 10th Annual Asbestos Disease Awareness Organization (ADAO) Asbestos Awareness and Prevention Conference took place in Washington, DC, from April 4 to 6, 2014. The event was an enlightening mix of knowledge and action, featuring prominent speakers such as Dr. Richard Lemen and Dr. Arthur Frank.

    A standout moment from the conference was the heart-wrenching tale from Michael Bradley, a mesothelioma patient, illustrating the stark reality with his statement: “Asbestos ruined my life.” The conference took a deep dive into the medical advancements in diagnosing and treating mesothelioma and other asbestos-related diseases. The chairperson for this enlightening session was the esteemed Christine Oliver, M.D.

    If you missed out on the event, don’t fret. A video of the conference is available on the ADAO website. You can catch up on what transpired during this significant event by visiting their newsroom or clicking here. This conference is a must-watch for anyone interested in asbestos-related legal issues, medical advancements, and personal experiences.

    Stay tuned to ADAO for more updates on asbestos disease awareness and prevention. Their commitment to providing valuable information makes them a go-to resource for anyone seeking to keep abreast with the latest news in asbestos and mesothelioma law.

    Original source: ADAO – Asbestos Disease Awareness Organization

  • 19th ADAO Asbestos Awareness and Prevention Conference in Washington, DC Videos (2024)

    Championing the cause for asbestos awareness, the 19th ADAO Asbestos Awareness and Prevention Conference was held in Washington, D.C. on September 14, 2024. This significant event brought to the forefront the compelling topic of “Exploring the Intersection of Asbestos Prevention, Policy, and the Law.” This conference was an essential hub for anyone interested in the latest developments in mesothelioma legal news.

    The conference was divided into numerous informative sessions, one of which was titled “Two Decades of Advocacy: Milestones, Challenges, and the Road Ahead.” This session was moderated by Ellen Costa, a renowned name in the field.

    Marilyn Amento, who sadly became a Mesothelioma widow, shared her heart-wrenching personal story of mesothelioma and her journey into advocacy in a segment titled “A Widow’s Voice”. Her experiences served as a reminder of the human cost of asbestos exposure, underscoring the importance of continued advocacy and prevention efforts.

    Adding to the rich dialogue, Linda Reinstein, a well-known advocate for asbestos awareness, presented on the theme of “Promoting Progress.” Her insights were invaluable to those seeking to understand the current state of asbestos prevention and the steps being taken towards progress.

    For those who were unable to attend, or who wish to revisit the thought-provoking sessions, videos from the 19th ADAO Asbestos Awareness and Prevention Conference are now available. These can be viewed on the Asbestos Disease Awareness Organization’s website, in the newsroom blogs section.

    The Asbestos Disease Awareness Organization (ADAO) continues to lead the charge in raising awareness and advocating for policy changes related to asbestos. Attending or revisiting their conferences is a great way to stay informed about the latest in asbestos prevention, policy, and legal news.

    Original source: ADAO – Asbestos Disease Awareness Organization

  • Honoring 2025 Rock & Roll Hall of Fame Inductee Warren Zevon: A Musical Genius, Mesothelioma Warrior, and an Unforgettable Voice

    As we move further into 2025, a long overdue recognition finally finds its way to none other than the iconic Warren Zevon. This year, the Rock & Roll Hall of Fame have finally given Zevon the honor of induction into the esteemed “Musical Influence” category. A recognition that has been long-awaited, it highlights not just Zevon’s musical prowess, but his wider influence as an artist.

    Warren Zevon was so much more than just a musician. He was an artist through and through – a master storyteller whose work went beyond the realm of music. Yet, his musical genius is undeniable and has left a lasting impact on rock and roll.

    But Zevon’s legacy encompasses more than just his music. He was also a vocal and brave warrior in his fight against mesothelioma – a rare and aggressive form of cancer that is often linked to asbestos exposure. His journey with the disease and his unyielding spirit in the face of adversity have made him an unforgettable voice in the world of mesothelioma advocacy.

    To read more about Warren Zevon’s musical journey, his fight with mesothelioma, and his induction into the Rock & Roll Hall of Fame, head to the Asbestos Disease Awareness Organization’s blog post: [“Honoring 2025 Rock & Roll Hall of Fame Inductee Warren Zevon: A Musical Genius, Mesothelioma Warrior, and an Unforgettable Voice”](https://www.asbestosdiseaseawareness.org/newsroom/blogs/warren-zevon-hall-of-fame/).

    Stay tuned to [ADAO – Asbestos Disease Awareness Organization](https://www.asbestosdiseaseawareness.org) for more updates and information on mesothelioma and asbestos-related diseases.

    Original source: ADAO – Asbestos Disease Awareness Organization

  • Action Mesothelioma Day 2025: ADAO Stands with UK Mesothelioma Warriors for Prevention and a Cure

    If you have a keen interest in mesothelioma legal news, then mark your calendars for an event you won’t want to miss! The London Asbestos Support Awareness Group (LASAG) is gearing up to host their annual Action Mesothelioma Day (AMD) event on Wednesday, July 2, at the prestigious City Hall in London.

    This influential event gathers together a dynamic mix of advocates, patients, scientists, and lawmakers. Its mission? To raise awareness about the dangers of asbestos exposure, remember those who have tragically lost their lives to mesothelioma, and to rally for urgent action in the realms of prevention and policy change.

    This year, the Asbestos Disease Awareness Organization (ADAO), a leading international advocate for those affected by asbestos-related diseases, will stand shoulder to shoulder with UK mesothelioma warriors in their battle for prevention and a cure.

    To learn more about this event and how you can get involved, visit the ADAO’s blog post “Action Mesothelioma Day 2025: ADAO Stands with UK Mesothelioma Warriors for Prevention and a Cure.” Let’s join hands and fight this deadly disease together.

    Original source: ADAO – Asbestos Disease Awareness Organization